Linda Rickardson

1.4k citations

28 papers · 1.1k indexed · h-index 18

Co-authors: Rolf Larsson Joachim Gullbo Peter Nygren Mårten Fryknäs Henrik Lövborg Malin Wickström Stig Linder Anders Isaksson
Topics: Cancer therapeutics and mechanisms (4 papers)Ubiquitin and proteasome pathways (4 papers)Cancer-related Molecular Pathways (4 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Nature Communications Biochemical and Biophysical Research Communications British Journal of Cancer
Partner nations: Sweden United States Germany

In The Last Decade

Linda Rickardson

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Linda Rickardson

Since Specialization

Citations

This map shows the geographic impact of Linda Rickardson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Rickardson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Rickardson more than expected).

Fields of papers citing papers by Linda Rickardson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Rickardson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Rickardson. The network helps show where Linda Rickardson may publish in the future.

Co-authorship network of co-authors of Linda Rickardson

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Rickardson. A scholar is included among the top collaborators of Linda Rickardson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Rickardson. Linda Rickardson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent 2017 ·Drug Design Development and Therapy ·Linda Rickardson,(unknown),(unknown),Marita Högberg,Marko J. Kallio,Stefan Rehnmark	5
2	Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia 2015 ·Blood Cancer Journal ·Anna Eriksson,(unknown),Syed Shams ul Hassan,Joachim Gullbo,Linda Rickardson,Malin Jarvius,Peter Nygren,Mårten Fryknäs,Martin Höglund,Rolf Larsson	46
3	Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments 2014 ·Nature Communications ·Xiaonan Zhang,Mårten Fryknäs,E Hernlund,Walid Fayad,Angelo De Milito,Maria Hägg Olofsson,Vladimir Gogvadze,Long H. Dang,Sven Påhlman,(unknown),Linda Rickardson,Pádraig D’Arcy,Joachim Gullbo,Peter Nygren,Rolf Larsson,Stig Linder	194
4	AKN-028 induces cell cycle arrest, downregulation of Myc associated genes and dose dependent reduction of tyrosine kinase activity in acute myeloid leukemia 2013 ·Biochemical Pharmacology ·Anna Eriksson,Antonia Kalushkova,Malin Jarvius,Riet Hilhorst,Linda Rickardson,Hanna Göransson Kultima,Rik de Wijn,(unknown),Mårten Fryknäs,Fredrik Öberg,Rolf Larsson,Vendela Parrow,Martin Höglund	12
5	Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance 2013 ·BMC Cancer ·Mårten Fryknäs,Joachim Gullbo,Xin Wang,Linda Rickardson,Malin Jarvius,Malin Wickström,Saadia Hassan,Claes Andersson,Mats Gustafsson,Gunnar Westman,Peter Nygren,Stig Linder,Rolf Larsson	8
6	Piperlongumine induces inhibition of the ubiquitin–proteasome system in cancer cells 2013 ·Biochemical and Biophysical Research Communications ·Malin Jarvius,Mårten Fryknäs,Pádraig D’Arcy,C. N. Sun,Linda Rickardson,Joachim Gullbo,Caroline Haglund,Peter Nygren,Stig Linder,Rolf Larsson	50
7	Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma 2012 ·BMC Cancer ·Lina Y. Dimberg,Anna Dimberg,(unknown),Mårten Fryknäs,Linda Rickardson,Gerard Tobin,Simon Ekman,Rolf Larsson,Urban Gullberg,Kenneth Nilsson,Fredrik Öberg,Helena Jernberg‐Wiklund	19
8	Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system 2012 ·Investigational New Drugs ·Jenny Felth,(unknown),Pádraig D’Arcy,Caroline Haglund,Joachim Gullbo,Rolf Larsson,Stig Linder,Lars Bohlin,Mårten Fryknäs,Linda Rickardson	20
9	Novel activity of acriflavine against colorectal cancer tumor cells 2011 ·Cancer Science ·Saadia Hassan,(unknown),Haile Mahteme,Jenny Felth,Mårten Fryknäs,Walid Fayad,Stig Linder,Linda Rickardson,Joachim Gullbo,Wilhelm Graf,Lars Påhlman,Bengt Glimelius,Rolf Larsson,Peter Nygren	54
10	Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties 2011 ·Chemical Biology & Drug Design ·Walid Fayad,Linda Rickardson,Caroline Haglund,Maria Hägg Olofsson,Pádraig D’Arcy,Rolf Larsson,Stig Linder,Mårten Fryknäs	37
11	Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment 2011 ·Biochemical Pharmacology ·Joachim Gullbo,Mårten Fryknäs,Linda Rickardson,Pádraig D’Arcy,Maria Hägg,Malin Wickström,Sadia Hassan,Gunnar Westman,Slavica Brnjic,Peter Nygren,Stig Linder,Rolf Larsson	13
12	High Content Screening for Inhibitors of Protein Interactions and Post-translational Modifications in Primary Cells by Proximity Ligation 2009 ·Molecular & Cellular Proteomics ·Karl‐Johan Leuchowius,Malin Jarvius,Malin Wickström,Linda Rickardson,Ulf Landegren,Rolf Larsson,Ola Söderberg,Mårten Fryknäs,Jonas Jarvius	62
13	Induction of the lysosomal apoptosis pathway by inhibitors of the ubiquitin‐proteasome system 2008 ·International Journal of Cancer ·Maria Berndtsson,Mélanie Beaujouin,Linda Rickardson,Aleksandra Mandic Havelka,Rolf Larsson,Jacob Westman,Emmanuelle Liaudet‐Coopman,Stig Linder	36
14	Rapamycin shows anticancer activity in primary chronic lymphocytic leukemia cellsin vitro, as single agent and in drug combination 2008 ·Leukemia & lymphoma ·Anna Åleskog,(unknown),Peter Nygren,Linda Rickardson,Meena Kanduri,Gerard Tobin,Magnus Åberg,Mats G. Gustafsson,Richard Rosenquist,Elin Lindhagen	18
15	Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro 2007 ·Investigational New Drugs ·Elin Lindhagen,Linda Rickardson,Gary Elliott,Lorenzo M. Leoni,Peter Nygren,Rolf Larsson,Anna Åleskog	7
16	Image-Based Screening for the Identification of Novel Proteasome Inhibitors 2007 ·SLAS DISCOVERY ·Linda Rickardson,Malin Wickström,Rolf Larsson,Henrik Lövborg	38
17	STAT1 signaling is associated with acquired crossresistance to doxorubicin and radiation in myeloma cell lines 2006 ·International Journal of Cancer ·Mårten Fryknäs,Sumeer Dhar,Fredrik Öberg,Linda Rickardson,Maria Rydåker,Hanna Göransson,Mats Gustafsson,Ulf Pettersson,Peter Nygren,Rolf Larsson,Anders Isaksson	53
18	Screening of an annotated compound library for drug activity in a resistant myeloma cell line 2006 ·Cancer Chemotherapy and Pharmacology ·Linda Rickardson,Mårten Fryknäs,Caroline Haglund,Henrik Lövborg,Peter Nygren,Mats G. Gustafsson,Anders Isaksson,Rolf Larsson	31
19	Phenotype-Based Screening of Mechanistically Annotated Compounds in Combination with Gene Expression and Pathway Analysis Identifies Candidate Drug Targets in a Human Squamous Carcinoma Cell Model 2006 ·SLAS DISCOVERY ·Mårten Fryknäs,Linda Rickardson,Malin Wickström,Sumeer Dhar,Henrik Lövborg,Joachim Gullbo,Peter Nygren,Mats G. Gustafsson,Anders Isaksson,Rolf Larsson	17
20	Inhibition of proteasome activity, nuclear factor-KB translocation and cell survival by the antialcoholism drug disulfiram 2005 ·International Journal of Cancer ·Henrik Lövborg,Fredrik Öberg,Linda Rickardson,Joachim Gullbo,Peter Nygren,Rolf Larsson	102

About Linda Rickardson

Linda Rickardson is a scholar working on Oncology, Pharmacology and Cancer Research, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Cancer Research (219 citations), Oncology (290 citations) and Molecular Biology (705 citations). Linda Rickardson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Rolf Larsson, Joachim Gullbo, Peter Nygren, Mårten Fryknäs, Henrik Lövborg, Malin Wickström, Stig Linder, Anders Isaksson, Pádraig D’Arcy and Fredrik Öberg. Their work appears in journals such as Nature Communications, Biochemical and Biophysical Research Communications and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact